Trial site
CTC Hodonin s.r.o.
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- High blood pressure3 trials
- Stroke3 trials
- Atrial fibrillation2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 315 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed7 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Arrowhead Pharmaceuticals3 trials
- Ionis Pharmaceuticals, Inc.2 trials
- Kailera2 trials
- Novo Nordisk A/S2 trials
- and 4 more
Running trials
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
Closed trials
Recruiting
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026